- Placebo This single center trial will be conducted in the United States. Participants will remain confined to the study site from check-in (Day -1) through Days 5 of each period in part 1 and through Day 18 in Part 2. Participants will be contacted by telephone 14±2 days after the last dose of study drug for follow-up assessment.